<DOC>
	<DOCNO>NCT01276002</DOCNO>
	<brief_summary>The disruption pancreatic duct seem major cause pseudocyst formation persistence patient suffer acute/chronic pancreatitis . No prospective randomize study conduct influence pancreatic duct stenting patient ` benefit recurrence rate . The aim fo study therefore evaluate prospectively randomize , control fashion patient wit pancreatic pseudocysts , wether pancreatic duct stenting disrupt pancreatic duct beneficial term quicker clinical recovery avoidance recurrence pancreatic pseudocysts .</brief_summary>
	<brief_title>Evaluation Pancreatic Duct Stenting Patients With Pancreatic Pseudocysts .</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatic Pseudocyst</mesh_term>
	<criteria>pancreatic pseudocyst , least 6 cm diameter symptomatic pancreatic pseudocyst increase size pancreatic pseudocyst within 6 week Pregnancy Age less 18 year Postoperative status prevent access papilla Allergy contrast prevent ERP Missing inform consent study PTT 1.5 time normal , unless substitute Platelet count less 50.000/Âµl , unless substitute Pancreatic ascites fistula Life expectancy le 2 year Percutaneously drain cyst part study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>disrupt duct</keyword>
	<keyword>pancreatic pseudocysts</keyword>
</DOC>